OctoPlus wins new drug delivery evaluation contract for two compounds
08-Jun-2009
- Netherlands
Under the contract OctoPlus will evaluate the feasibility of two controlled release formulations that combine the active ingredients of the client with OctoPlus' proprietary drug delivery technology. If the evaluations are successful, the contract may progress to a full process development, manufacturing and licensing agreement.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.